Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme
| 針對症狀 | Brain and Central Nervous System Tumors |
| 臨床試驗編號 | NCT00331526 |
| 臨床階段 | Phase II |
| 臨床試驗位址 | Hoag Cancer Institute at Hoag Memorial Hospital Presbyterian |
| 目前研究進度 | This study has been completed. |
| 試驗開始日期 | May 30, 2006 |
| 試驗開始日期 | October 1, 2011 |
| 臨床目的 |
RATIONALE: Biological therapies, such as cellular adoptive immunotherapy, may stimulate the immune system in different ways and stop tumor cells from growing. Aldesleukin may stimulate the white blood cells, including lymphokine-activated killer cells, to kill tumor cells. Giving cellular adoptive immunotherapy during or after surgery may kill more tumor cells. PURPOSE: This phase II trial is studying how well cellular adoptive immunotherapy works in treating patients with glioblastoma multiforme. |